← Open Payments lookup

KACEY LOHMANN: Open Payments

NPI 1962861930 · GILBERT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,352 in 36 payments from 13 companies in 2025. Trend: 2023 $543 · 2024 $245 · 2025 $1,352

Food & beverage: $1,352
CompanyPaymentsAmount
Madrigal Pharmaceuticals6$298
Janssen Biotech, Inc.7$253
Phathom Pharmaceuticals, Inc.4$189
GENZYME CORPORATION3$159
Gilead Sciences, Inc.3$127
ABBVIE INC.4$91
Takeda Pharmaceuticals U.S.A., Inc.2$52
Ipsen Biopharmaceuticals, Inc2$40
QOL Medical, LLC1$37
Ardelyx, Inc.1$32

Products named: REZDIFFRA, TREMFYA, VOQUEZNA, DUPIXENT, RINVOQ, Linzess, IQIRVO, Sucraid.

Industry payments across AZ — which companies pay providers there.